ImmunityBio, Inc. — SEC 8-K Filing
ImmunityBio
Mar 31, 2026
Tracking 55 healthcare M&A deals in California. Recent activity spans Healthcare Services Other, Medical Devices, Pharmacy, Pharmaceuticals. California ranks #1 of 41 states for healthcare deal volume.
ImmunityBio
Mar 31, 2026
Aurinia Pharma→Kezar Life Sciences
Mar 30, 2026
Merck Sharp & Dohme→Terns Pharmaceuticals
Mar 25, 2026
Danaher→Masimo
Mar 18, 2026
Semnur Pharmaceuticals
Mar 17, 2026
Servier→Day One Biopharmaceuticals
Mar 6, 2026
Gyre Therapeutics→Cullgen
Mar 2, 2026
Feb 17, 2026
XOMA Royalty→Generation Bio
Feb 9, 2026
ClearPoint Neuro→IRRAS Holdings
Feb 5, 2026
Town Square→Pair Team
Jan 23, 2026
HCAP Partners→Core Analytics Lab & Radiology
Jan 13, 2026
ABS Bio→Cureline
Jan 6, 2026
PAI Pharma→Nivagen Pharmaceuticals
Jan 6, 2026
Sobi→Arthrosi Therapeutics
Jan 5, 2026